Total Payments
$4,680
2024 Payments
$1,529
Companies
26
Transactions
249
Medicare Patients
5,614
Medicare Billing
$939,821
Payment Breakdown by Category
Food & Beverage$4,553 (97.3%)
Education$127.00 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,553 | 246 | 97.3% |
| Education | $127.00 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,450 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,022 | 73 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $579.31 | 27 | $0 (2024) |
| GENZYME CORPORATION | $290.82 | 18 | $0 (2024) |
| Philips Electronics North America Corporation | $188.01 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $151.84 | 11 | $0 (2023) |
| Genentech USA, Inc. | $146.59 | 4 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $109.27 | 7 | $0 (2024) |
| Mylan Specialty L.P. | $96.38 | 6 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $94.67 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,529 | 74 | AstraZeneca Pharmaceuticals LP ($470.47) |
| 2023 | $1,148 | 70 | AstraZeneca Pharmaceuticals LP ($385.05) |
| 2022 | $1,239 | 70 | AstraZeneca Pharmaceuticals LP ($391.53) |
| 2021 | $461.40 | 28 | Regeneron Healthcare Solutions, Inc. ($145.57) |
| 2020 | $36.59 | 2 | Mylan Specialty L.P. ($21.14) |
| 2019 | $141.49 | 4 | Genentech USA, Inc. ($99.99) |
| 2017 | $125.47 | 1 | AstraZeneca Pharmaceuticals LP ($125.47) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $107.63 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardio-pulmonary | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Narcoplepsy | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,455 | 2,468 | $631,024 | $228,523 |
| 2022 | 20 | 1,428 | 2,252 | $577,612 | $204,523 |
| 2021 | 15 | 1,342 | 2,294 | $606,634 | $217,665 |
| 2020 | 7 | 1,389 | 2,707 | $508,291 | $289,110 |
Total Patients
5,614
Total Services
9,721
Medicare Billing
$939,821
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 290 | 801 | $130,746 | $54,004 | 41.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 195 | 446 | $108,646 | $45,019 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 105 | 222 | $132,312 | $40,224 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 318 | $90,312 | $33,077 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 126 | 132 | $38,412 | $14,538 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 69 | $27,255 | $10,587 | 38.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 68 | $29,240 | $9,993 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $18,615 | $6,694 | 36.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 94 | 95 | $17,575 | $4,815 | 27.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 90 | 90 | $13,050 | $3,507 | 26.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 85 | 86 | $10,320 | $2,064 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 18 | $4,394 | $1,766 | 40.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 34 | 34 | $6,800 | $1,141 | 16.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 18 | 21 | $2,310 | $616.35 | 26.7% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 12 | 17 | $1,037 | $475.52 | 45.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 114 | 238 | $141,848 | $44,061 | 31.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 286 | 672 | $104,160 | $40,099 | 38.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 218 | 429 | $94,809 | $37,006 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 178 | $50,552 | $19,466 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 94 | $40,420 | $15,273 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 69 | 84 | $33,069 | $13,040 | 39.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 78 | 80 | $23,280 | $8,825 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $14,165 | $5,326 | 37.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 91 | 96 | $17,760 | $5,150 | 29.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 89 | 94 | $13,630 | $3,725 | 27.3% |
About Dr. David Baumgarten, MD
Dr. David Baumgarten, MD is a Pulmonary Disease healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1770920720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Baumgarten, MD has received a total of $4,680 in payments from pharmaceutical and medical device companies, with $1,529 received in 2024. These payments were reported across 249 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,553).
As a Medicare-enrolled provider, Baumgarten has provided services to 5,614 Medicare beneficiaries, totaling 9,721 services with total Medicare billing of $939,821. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Cherry Hill, NJ
- Active Since 05/31/2013
- Last Updated 05/27/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1770920720
Products in Payments
- DUPIXENT (Biological) $870.13
- BREZTRI (Drug) $513.65
- TRELEGY ELLIPTA (Drug) $489.03
- NUCALA (Biological) $381.81
- FASENRA (Biological) $286.50
- TEZSPIRE (Biological) $210.38
- (8874) inCourage (Device) $188.01
- SYMBICORT (Drug) $148.22
- STIOLTO RESPIMAT (Drug) $133.82
- AIRSUPRA (Drug) $125.81
- AREXVY (Drug) $125.00
- XYWAV (Drug) $109.27
- Esbriet (Biological) $99.99
- (AK6) Vest Therapy (Device) $67.66
- OPSUMIT (Drug) $63.75
- YUPELRI (Drug) $62.26
- WAKIX (Drug) $59.72
- Impella (Device) $50.58
- Xolair (Biological) $46.60
- Adempas (Drug) $35.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cherry Hill
Dr. Steven Baumgarten, M.d, M.D
Pulmonary Disease — Payments: $9,230
Pulmonary Disease $9,230
Ira Horowitz, M.d, M.D
Pulmonary Disease — Payments: $7,417
Pulmonary Disease $7,417
Dr. Nicholas Roy, D.o, D.O
Pulmonary Disease — Payments: $5,534
Pulmonary Disease $5,534
Steffi Lena, D.o, D.O
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829
Dr. Alan Pope, M.d, M.D
Pulmonary Disease — Payments: $1,164
Pulmonary Disease $1,164
Dipakkumar Malli, Md, MD
Pulmonary Disease — Payments: $134.02
Pulmonary Disease $134.02